Company: LGN
Filing Date: 2025-02-14
Form Type: DRS
Source: 0000950123-25-002471
Chunk: 87

Company: Legence Corp.
Filing Date: 2025-02-14
Form: DRS
Chunk 87
---
 this offering, our
Sponsor will control a majority of our voting power. As a result, we will be a “controlled company” within the meaning of the corporate governance standards. Under the rules, a company of which
more than 50% of the voting power is held by an individual, group or another company is a “controlled company” and need not comply with certain requirements, including the requirement that a majority of the board of directors consist of
independent directors and the requirements that our compensation and nominating and governance committees be composed entirely of independent directors. Following this offering, we do not intend to utilize these exemptions, However, for so long as
we qualify as a “controlled company,” we will maintain the option to utilize some or all of these exemptions. If we utilize these exemptions, we may not have a majority of independent directors and our compensation and nominating and
governance committees may not consist entirely of independent directors, and such committees will not be subject to annual performance evaluations. Accordingly, in the event we elect to rely on these exemptions in the future, you may not have the
same protections afforded to stockholders of companies that are subject to all of the corporate governance requirements of the . See “Management—Status as a Controlled Company.”

54

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

If we fail to effectively maintain and scale our financial and risk management controls and procedures, we may expose our business to audit or legal risk.

As a private company, we have not been required to document and test our
internal controls over financial reporting nor has our management been required to certify the effectiveness of our internal controls and our auditors have not been required to opine on the effectiveness of our internal control over financial
reporting. Failure to maintain adequate financial, information technology and management processes and controls could result in material weaknesses which could lead to errors in our financial reporting, which could have a material adverse impact on
our business, financial condition and results of operations.

Future sales of our Class A Common Stock or LGN Units in the public market could reduce the market price of our Class A Common Stock, and any additional capital raised by us through the sale of equity or convertible or exchangeable securities may dilute your ownership in us.

We may sell additional shares of Class A Common Stock in subsequent public offerings. We may also issue additional shares of Class A
Common Stock or convertible or exchangeable securities (including LGN Units).